The UCI ADRC Neuropathology Core (NP) plays a key role in providing high quality tissue resources to support research dedicated to the study of normal and pathological aging. To accomplish the ADRC goals, the NP Core interacts intimately with the Clinical, Data Management and Statistics (DMS), Education and Information Transfer (EIT), and Administrative cores. The NP Core generates resources to support the study of mechanisms of neurodegeneration and plasticity, with a focus on Alzheimer's disease, other neurodegenerative diseases and the oldest old. The NP Core links clinical evaluations and diagnoses with definitive pathological diagnoses, and provides well-characterized tissue samples to basic scientists to stimulate and facilitate research in Alzheimer's disease, other age-associated neurodegenerative diseases, and aging. Providing tissues that have been characterized clinically and neuropathologically draws in experienced researchers and attracts young investigators to the field. To achieve these goals, the Neuropathology Core has eight aims: (1) obtain brain tissue from ADRC subjects evaluated by the Clinical Core;(2) provide accurate and timely final neuropathology diagnoses to families as well as to the Clinical, and DMS;(3) maintain and continue to develop a Brain Tissue Repository that maximizes the use of tissue for diagnostic and research purposes;(4) disseminate brain, plasma, serum, and cerebrospinal fluid samples from clinically characterized autopsy cases to investigators;(5) develop custom peptides and antibodies to support dementia research, with an emphasis on beta-amyloid peptides and antibodies;(6) develop, maintain and share an inventory of serum, plasma, and DNA samples from living subjects to support longitudinal studies;(7) support a triple, double, and single transgenic mouse brain tissue inventory by banking tissues from different lines of mice at different ages and;(8) provide biochemical measures of beta-amyloid on autopsy cases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG016573-10
Application #
7848209
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
10
Fiscal Year
2009
Total Cost
$406,436
Indirect Cost
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Cox, Chelsea G; Ryan B A, Mary M; Gillen, Daniel L et al. (2018) A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. Am J Geriatr Psychiatry :
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Agrawal, Sudhanshu; Abud, Edsel M; Snigdha, Shikha et al. (2018) IgM response against amyloid-beta in aging: a potential peripheral protective mechanism. Alzheimers Res Ther 10:81
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 518 publications